Array Biopharma Inc (NASDAQ:ARRY) shares were soaring 17% yesterday on back of a second fiscal quarter update that has given investors signs of …
Griffin analyst Keith Markey sees golden prospects ahead for ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), particularly taking into account the seven clinical trials the firm has …
Though Cognizant Technology Solutions Corp (NASDAQ:CTSH) underwhelmed slightly on revenue and 2017 guidance when it released fourth-quarter results yesterday, the firm’s quarterly non-GAAP …
Analysts are reiterating buys on Gilead Sciences, Inc. (NASDAQ:GILD) and Amgen, Inc.
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) announced on Monday that Richard Glickman would be taking on new roles as chairman and CEO of the firm …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares are falling nearly 7% following CEO Erez Vigodman’s exit, leaving current chairman Dr. Yitzhak Peterburg to …
Morgan Stanley analyst Francois Meunier has high hopes for Nokia Corp (ADR) (NYSE:NOK), upgrading the stock from Equalweight to Overweight. Nokia shares are currently trading …
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) revealed yesterday evening that its Board of Directors has chosen Dr. Richard Glickman, the biotech firm’s founder and Chairman, …
Top analyst Michael Walkley at Canaccord sees bullish forecasts ahead for Apple Inc. (NASDAQ:AAPL) and QUALCOMM, Inc.
Aratana Therapeutics Inc (NASDAQ:PETX) shares were falling nearly 18% on the heels of Friday’s announcement revealing that Entyce, approved in the U.S.
